⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockFranceNasdaqGS

NBTX

Nanobiotix S.A.

Healthcare · Biotechnology

36.64USD

-1.5500 (-4.06%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End12/2025 Q4
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 36.64
P/E—
Dvd Ind Yld—
P/B—
P/S62.8
Curr EV/T12M EBITDA—
Mkt Cap (USD)1.9B
Curr EV (USD)—
2)

Per Share Data

EPS T12M-0.50
DPS—
Bk Val Per Sh-2.02
Rev/Sh0.62
Cash/Sh1.09
Curr Shares Out50.8M
FCF/Sh-0.71
3)

Cash Flow Analysis

P/CF-55.7
Curr P/FCF-54.8
CF/NI1.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-112.7%
Eff Interest Rate14.9%
4)

Growth Potential

Dil EPS 1Y Gr65.3%
Cap 1Y Gr140.7%
BPS 1Y Gr-27.1%
R&D To Sales78.0%
Retention Rate100.0%
Rev 1Y Gr355.3%
FCF 1Y Gr-66.5%
Assets 1Y Gr0.5%
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin-36.5%
Pretax Margin-80.8%
Net Margin-80.8%
ROA-37.6%
ROE43.0%
ROC—
Asset Turnover0.46
6)

Structure

Current Ratio1.09
Quick Ratio1.05
Debt/Assets136.1%
Debt/Com Eq-109.2%
Net Debt/EBITDA-4.23
Tot Debt/Capital1191.9%
Gross Margin100.0%
EBIT/Int Exp-1.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.